Johnny Rice

Data Security in the Age of Cyber Threats: How Companies Can Safeguard Their Future

As technology advances and the digital landscape expands, data security has become an increasingly pressing concern for companies. The rise in cyber threats has put businesses at risk, making it crucial for organizations to take proactive steps to...

Innovative Smart Home Gym Takes a Leap into MultiFamily Market Through New Partnership

Trent Ward, the CEO of Interactive Strength, known as FORME (NASDAQ: TRNR), recently appeared as a guest on Benzinga's All-Access. FORME is a digital fitness service that offers cutting-edge smart home gyms combined with personalized training from real...

Is Bone Marrow the Key to Curing Alzheimer’s? Biotech Company Reports Promising Results from Clinical Trial

In a recent interview on Benzinga's All-Access, Wa'el Hashad, the CEO of Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company, revealed exciting developments.Longeveron specializes in developing cellular therapies derived from the bone marrow of young healthy adult donors, with...

This Lithium Miner: A Key Player in the North American Lithium Supply Chain

In a recent interview with Benzinga, Jason Barnard, CEO & President of Foremost Lithium (FMST), shed light on the company's impressive track record and unique position in the lithium mining industry. Foremost Lithium is a leading player in the...

Discover the Hidden Gems of the Electric Vehicle Market: Investing in Industrial EVs

Are you caught up in the frenzy surrounding Tesla and Rivian? While these companies dominate the headlines, there's another player in the electric vehicle (EV) market that shouldn't be overlooked: Greenland Technologies Holdings (GTEC). Led by CEO Raymond...

This Thriving E-Commerce Business: A Closer Look at CarParts.com

In a special edition of All-Access hosted by Luke Jacobi, Benzinga had the privilege of interviewing David Meniane, the CEO of CarParts.com (NASDAQ: PRTS), an e-commerce company that offers a factory-to-consumer online shopping experience for everyday drivers.With 20...

Arianne Phosphate Updates Investors On State Of The Company After Exciting Year

Brian Ostroff, President and Director of Arianne Phosphate Inc. (ticker:...

Disease With Market Estimated At $3.9 Billion Lacks Cure – Will This Company Be The First To Find One?

GRI BIO GRI is a dynamic clinical-stage biotechnology firm on the forefront of revolutionizing healthcare by groundbreaking scientific developments. The corporate is concentrated on essentially altering how inflammatory, fibrotic and autoimmune ailments are handled.When the physique’s immune system is...

Innovative Biotech Company Announces Agreement To Perform CBD Pill Clinical Study

Dr. Jim Woody, CEO of 180 Life Sciences Corp. ATNF, was just lately a visitor on Benzinga’s All-Entry.180 Life Sciences is a clinical-stage biotechnology firm targeted on the event of novel medicine that fulfill unmet wants in inflammatory illnesses,...

Revolutionizing Arrhythmia Treatment: How BioSig Is Transforming Medical Device Technology

An Innovator in Medical Device Technology Ken Londoner, the CEO of BioSig Technologies (BSGM), recently appeared on Benzinga's All-Access to discuss the groundbreaking work being done by the company. The PureEP Platform: A Game-Changer in Arrhythmia Treatment BioSig Technologies, a pioneer...